Company
Teva Pharmaceutical Industries
NASDAQ:TEVA
Teva Pharmaceutical Industries develops, produces and markets generic drugs covering a wide range treatment categories.
11 stories
Imugene appoints global pharmaceutical executive to its board
Dr. Lesley Russell brings extensive pharmaceutical experience to the board including a number of cancer therapy collaborations with Teva Pharmaceuticals.
Teva shares surge on news of further restructuring, massive job cuts
The company will immediately suspend its dividend and cancel its 2017 bonus program
Teva Pharmaceutical names Danish industry veteran Kare Schultz as its new chief executive
The new chief executive joins Teva - the world's biggest seller of generics medicines - from Denmark's H. Lundbeck A/S, where he has been president and CEO since May 2015
AstraZeneca "to miss out on US drug deal" - sources
Receptos is said to have rebuffed $200 per share bid approach from AstraZeneca